医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

MabPlex Announces Xinfang Li as Vice President of Process Development

2018年01月09日 PM09:00
このエントリーをはてなブックマークに追加


 

FREMONT, Calif. & YANTAI, SHANDONG, China

MabPlex International, a world class CDMO for biologics, announced the appointment of Xinfang Li, Ph.D., to Vice President of Process Development. Dr. Li has more than 20 years of experience in biologics. Most recently she served as the Head of Downstream Product Purification at Immunogen.

“Xinfang has a tremendous amount of experience in our core competencies of antibody drug conjugate and recombinant protein development and manufacturing. The addition of Dr. Li to our team will further enhance our position as a world leading biologics CDMO,” commented Jianmin Fang, Ph.D., CEO of MabPlex International.

Along with her experience at Immunogen, Dr. Li holds multiple patents and publications in antibody drug conjugate preparation and purification technologies. In addition to her commercial experience, she is an expert in viral clearance. Xinfang obtained her Ph.D. in Molecular Biology and Biochemistry from Peking University in Beijing, China. From there, she went on to pursue her Post Doctorate at Harvard University in Boston, MA.

About MabPlex

MabPlex, founded in 2013, specializes in providing complete biologics development and manufacturing solutions to customers globally with our services from cell line development and process development to GMP manufacturing. Our technical expertise allows us to provide effective and high-quality solutions for monoclonal antibody and ADC therapeutics to the biopharmaceutical industry. With this, MabPlex delivers our commitment to our partners through our quality manufacturing, meeting their expectations.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180109005793/en/

CONTACT

MabPlex USA, Inc.
Bethanne Deuel, MBA, 1-800-925-3608
Director
of Marketing and Communications
bdeuel@us.mabplex.com
www.mabplex.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Seoul Viosys’ Violeds Modules Proven to Disinfect 99% of Airborne Viruses in a Recent Testing Result
  • Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan
  • Kaye推出适用于冷链运输市场的Kaye® Log -80℃ 疫苗温度记录器,以满足COVID-19疫苗储存和运输的要求
  • Kaye® (ケイ)は、COVID-19ワクチンの輸送・保管のニーズに応えるためにKaye® ログ -80ワクチン温度ロガーを、コールドチェーン市場向けに導入(発売)します。
  • DNP的新型非接触式透明屏幕可通过手的动作进行操作